title: Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations.
abstract: OBJECTIVE
  Germline mutations in the MEN1 gene predispose to the multiple endocrine neoplasia (MEN1) syndrome; however, approximately 10-20% of patients with MEN1 do not have a detectable MEN1 mutation. A rat strain with multiple endocrine tumours, a phenotypic overlap of both MEN1 and MEN2, has been reported to have a homozygous germline p27 (CDKN1B) mutation. Recently, two MEN1 mutation-negative MEN1 syndrome patients have been identified to harbour a germline CDKN1B mutation. The recently identified gene AIP can also cause familial isolated pituitary adenoma, but no other specific tumour is associated with this syndrome. The objective of this study was to evaluate the possible contribution of CDKN1B and AIP germline mutations in a cohort of MEN1 mutation-negative MEN1 syndrome patients.
  
  
  METHODS
  Eighteen sporadic and three familial cases of MEN1 mutation-negative MEN1 syndrome were studied (18 pituitary adenomas, 12 hyperparathyroidism, 10 neuroendocrine tumours including 2 ACTH-secreting lesions and one adrenal nodular hyperplasia). Clinical data and genomic DNA were analysed for mutations in the CDKN1B and AIP genes.
  
  
  RESULTS
  There were no mutations in the coding region or exon/intron junction of the CDKN1B and AIP genes in any patient. Although we have a limited number of patients in our cohort, our data is consistent with others in the literature suggesting that CDKN1B and AIP mutations are extremely rare in MEN1 syndrome.
  
  
  CONCLUSIONS
  Our results suggest that mutations in the CDKN1B and AIP genes are relatively uncommon in MEN1 mutation-negative MEN1 syndrome patients.
authors: Department of Endocrinology, Barts and the London School of Medicine, London, UK.
authors: Susana
authors: S
authors: Igreja
authors: Harvinder S
authors: HS
authors: Chahal
authors: Scott A
authors: SA
authors: Akker
authors: Maria
authors: M
authors: Gueorguiev
authors: Vera
authors: V
authors: Popovic
authors: Svetozar
authors: S
authors: Damjanovic
authors: Pia
authors: P
authors: Burman
authors: John A
authors: JA
authors: Wass
authors: Richard
authors: R
authors: Quinton
authors: Ashley B
authors: AB
authors: Grossman
authors: Márta
authors: M
authors: Korbonits
mesh_terms: D000328:Adult; D000368:Aged; D015331:Cohort Studies; D050760:Cyclin-Dependent Kinase Inhibitor p27; D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics; D018095:Germ-Line Mutation / Q000235:genetics*; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D018761:Multiple Endocrine Neoplasia Type 1 / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D055771:Serbia; D006113:United Kingdom
chemical_list: C436291:CDKN1B protein, human; D047908:Intracellular Signaling Peptides and Proteins; C105373:MEN1 protein, human; D011518:Proto-Oncogene Proteins; C103265:aryl hydrocarbon receptor-interacting protein; D050760:Cyclin-Dependent Kinase Inhibitor p27